PGHL.NS
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Performance Graph
Financial Ratios
Ratio Value
PE Ratio41.67
Net Profit Margin0.18
Acid Test Ratio1.90
Inventory Turnover3.29
Coverage Ratio27.59
Debt to Equity0.02
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: High income of the company when compared with its equity, which means efficient equity

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.18
Return on Assets2.15
Return on Equity0.37
Performance Graph
Key Ratios

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It would not have any issues to cover its short-term liabilities because of strong liquidity

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio1.90
Current Ratio2.39
Performance Graph
Key Ratios

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover3.29
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio27.59
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.02
Interest Coverage Ratio380.61
Performance Graph
Key Ratios

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Dividend Yield: Low yield, focus on growth rather than dividends (Low dividend yield, which means company is focusing on growth

Performance Graph
Market Ratios
Ratio Value
P/E Ratio41.67
Gross Profit Margin0.68
Price to Book Ratio15.56
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Procter & Gamble Health Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 7943600000 11011900000 8937200000
Total Non Current Assets 2701400000 3050900000 2800800000
Other Non Current Assets 18900000 93000000 -6900000
Non Current Prepaid Assets 923200000 968100000 1021800000
Non Current Deferred Taxes Assets 336900000 253200000 196500000
Financial Assets - - -
Investment In Financial Assets 62400000 50900000 87600000
Held To Maturity Securities - - -
Available For Sale Securities 62400000 50900000 87600000
Financial Assets Fair Value - - -
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 9600000 9400000 400000
Other Intangible Assets 9600000 9400000 400000
Goodwill - - -
Net Ppe 1315300000 1734700000 1496200000
Accumulated Depreciation -961800000 -1204700000 -1304500000
Gross Ppe 2277100000 2939400000 2800700000
Construction In Progress 58900000 326900000 406000000
Other Properties 1256400000 1407800000 1090200000
Machinery Furniture Equipment 1437600000 1854600000 1716900000
Buildings And Improvements 775600000 752900000 672800000
Land And Improvements 5000000 5000000 5000000
Properties - - -
Current Assets 5242200000 7961000000 6136400000
Other Current Assets 613300000 911400000 746700000
Hedging Assets Current - - -
Assets Held For Sale Current 90000000 - -
Restricted Cash 58600000 51700000 51300000
Prepaid Assets 613300000 911400000 814300000
Inventory 1091100000 1349400000 1152100000
Other Inventories - - 547700000
Finished Goods 547000000 492800000 547700000
Work In Process 72700000 135600000 109200000
Raw Materials 471400000 721000000 495200000
Other Receivables 150900000 140900000 90300000
Taxes Receivable - - -
Accounts Receivable 853300000 1157100000 834400000
Allowance For Doubtful Accounts Receivable -41900000 -39500000 -27100000
Gross Accounts Receivable 895200000 1196600000 861500000
Cash Cash Equivalents And Short Term Investments 2385000000 4350500000 3194000000
Other Short Term Investments 192300000 177300000 125900000
Cash And Cash Equivalents 2385000000 4350500000 3194000000
Cash Equivalents 1497700000 3396300000 2814000000
Cash Financial 887300000 954200000 380000000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt - - -
Total Debt 95600000 120000000 28300000
Total Liabilities Net Minority Interest 2561200000 3503000000 2772300000
Total Non Current Liabilities Net Minority Interest 372100000 464000000 414000000
Other Non Current Liabilities 6900000 6500000 6000000
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans 296400000 368700000 408000000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities - - -
Long Term Debt And Capital Lease Obligation 68800000 88800000 -
Long Term Capital Lease Obligation 68800000 88800000 -
Long Term Debt - - -
Long Term Provisions 296400000 368700000 408000000
Current Liabilities 2189100000 3039000000 2358300000
Other Current Liabilities 125300000 89200000 92400000
Current Deferred Taxes Liabilities 34500000 61300000 72400000
Current Debt And Capital Lease Obligation 26800000 31200000 28300000
Current Capital Lease Obligation 26800000 31200000 28300000
Current Debt - - -
Pension And Other Post Retirement Benefit Plans Current 102400000 182400000 102600000
Current Provisions 102400000 182500000 102600000
Payables 1984300000 2758600000 2149400000
Other Payable 171500000 252700000 251200000
Dividends Payable 58600000 51700000 51300000
Total Tax Payable 84200000 83800000 86800000
Accounts Payable 1670000000 2370400000 1760100000
Common Stock Equity 5382400000 7508900000 6164900000
Total Capitalization 5382400000 7508900000 6164900000
Total Equity Gross Minority Interest 5382400000 7508900000 6164900000
Minority Interest - - -
Stockholders Equity 5382400000 7508900000 6164900000
Other Equity Interest 85300000 78400000 72800000
Treasury Stock - - -
Retained Earnings 1575700000 3709100000 2370700000
Additional Paid In Capital 113900000 113900000 113900000
Capital Stock 166000000 166000000 166000000
Common Stock 166000000 166000000 166000000

Income statement interpretation for Procter & Gamble Health Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 11294900000 12058600000 11144100000
Operating Revenue 11294900000 12058600000 11144100000
Cost Of Revenue 3594900000 3921300000 3398000000
Gross Profit 7700000000 8137300000 7746100000
Ebitda 3014400000 3430700000 2808700000
Ebit 2740400000 3149700000 2537900000
Operating Income 2791100000 2958500000 2413300000
Net Income 2009800000 2294700000 1925200000
Net Income From Continuing Operation Net Minority Interest 2009800000 2294700000 1925200000
Net Income From Continuing And Discontinued Operation 2009800000 2294700000 1925200000
Net Income Common Stockholders 2009800000 2294700000 1925200000
Net Income Including Noncontrolling Interests 2009800000 2294700000 1925200000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 2009800000 2294700000 1925200000
Normalized Income 2163414700 2284036800 1930746813
Normalized Ebitda 3221400000 3416300000 2816000000
Total Unusual Items -207000000 14400000 -7300000
Total Unusual Items Excluding Goodwill -207000000 14400000 -7300000
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 274000000 281000000 270800000
Reconciled Cost Of Revenue 3594900000 3921300000 3398000000
Total Expenses 8503800000 9100100000 8730800000
Operating Expense 4908900000 5178800000 5332800000
Other Operating Expenses 1775700000 2014500000 3386400000
Depreciation And Amortization In Income Statement 274000000 281000000 270800000
Amortization - - -
Depreciation Income Statement 274000000 281000000 270800000
Selling General And Administration 876300000 990700000 1327700000
Selling And Marketing Expense 526500000 744900000 1094500000
General And Administrative Expense 349800000 245800000 233200000
Rent And Landing Fees 3700000 4700000 5600000
Tax Provision 723400000 847300000 608500000
Pretax Income 2733200000 3142000000 2533700000
Other Non Operating Income Expenses 36300000 30100000 131900000
Special Income Charges -207000000 14400000 -7300000
Other Special Charges 207000000 -7100000 5400000
Write Off - -7300000 7300000
Net Non Operating Interest Income Expense 110100000 135600000 -4200000
Total Other Finance Cost - - -
Interest Expense Non Operating 7200000 7700000 4200000
Interest Income Non Operating 117300000 143300000 110700000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 121.00 138.00 115.98
Basic Eps 121.00 138.00 115.98
Diluted Ni Avail To Com Stockholders 2009800000 2294700000 1925200000
Net Income From Continuing Operations 2733200000 3142000000 2533700000
Minority Interests - - -

Cash flow analysis for Procter & Gamble Health Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 2282900000 2360000000 1695200000
Changes In Cash -1966900000 1160300000 -1446500000
Taxes Refund Paid -851900000 -896600000 -638600000
Change In Working Capital -121200000 -300200000 -473000000
Change In Other Current Liabilities -110800000 32100000 83800000
Change In Other Current Assets 182700000 -318400000 -220100000
Change In Payable -716100000 639200000 -65000000
Change In Inventory 231300000 -323900000 -20200000
Change In Receivables 291700000 -329200000 -251500000
Other Non Cash Items -131100000 -156100000 -127800000
Stock Based Compensation 6900000 5600000 34100000
Provision And Write Off Of Assets -74500000 51700000 -59400000
Depreciation And Amortization 274000000 281000000 270800000
Amortization Cash Flow - - -
Depreciation 274000000 281000000 270800000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -68700000 -215000000 -255400000
Net Other Investing Changes 22400000 67900000 25000000
Interest Received Cfi 126200000 141900000 98800000
Dividends Received Cfi - - -
Net Investment Purchase And Sale - - -
Sale Of Investment - - -
Purchase Of Investment - - -
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -217300000 -424800000 -379200000
Sale Of Ppe - - -
Purchase Of Ppe -217300000 -424800000 -379200000
Net Intangibles Purchase And Sale - - -
Purchase Of Intangibles - - -
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -4181100000 -984700000 -2886300000
Net Other Financing Charges - - -
Interest Paid Cff - - -
Cash Dividends Paid -4149900000 -937900000 -2838500000
Common Stock Dividend Paid - - -
Net Common Stock Issuance - - -
Common Stock Payments - - -
Common Stock Issuance - - -
Repurchase Of Capital Stock - - -
Repayment Of Debt - - -
Issuance Of Debt - - -
Issuance Of Capital Stock - - -
Net Issuance Payments Of Debt - - -
Net Short Term Debt Issuance - - -
Short Term Debt Issuance - - -
Net Long Term Debt Issuance - - -
Long Term Debt Payments - - -
Long Term Debt Issuance - - -
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of PGHL.NS (Procter & Gamble Health Limited)

Above is the summary for fundamental analysis of Procter & Gamble Health Limited , whose ticker name is PGHL.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Procter & Gamble Health Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 41.67, PGHL.NS has a net profit margin of 0.18, the acid test ratio for PGHL.NS is 1.90, PGHL.NS has an inventory turnover of 3.29, and PGHL.NS has debt-to-equity ratio of 0.02.

The PGHL.NS whose company name is Procter & Gamble Health Limited has made profit/loss of 7700000000 with total revenue of 11294900000, PGHL.NS has assets worth of 7943600000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter